{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT04048278",
            "orgStudyIdInfo": {
                "id": "2017-1365"
            },
            "organization": {
                "fullName": "University of Illinois at Chicago",
                "class": "OTHER"
            },
            "briefTitle": "Lidocaine Infusion in Pancreatic Cancer",
            "officialTitle": "Lidocaine Infusion in Pancreatic Cancer: Translational Studies in a Preclinical Model And Human Subjects",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "lidocaine-infusion-in-pancreatic-cancer"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-11",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2018-11-08",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-11-08",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-01-01",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2019-06-18",
            "studyFirstSubmitQcDate": "2019-08-06",
            "studyFirstPostDateStruct": {
                "date": "2019-08-07",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-11-30",
            "lastUpdatePostDateStruct": {
                "date": "2023-12-01",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Effrossyni Votta-Velis",
                "investigatorTitle": "Associate Professor",
                "investigatorAffiliation": "University of Illinois at Chicago"
            },
            "leadSponsor": {
                "name": "University of Illinois at Chicago",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": true
        },
        "descriptionModule": {
            "briefSummary": "This study elucidates the effects of the intravenous (IV) lidocaine infusion on the biology of pancreatic circulating tumor cells (CTCs) isolated from patients undergoing robotic pancreatectomy for all types of pancreatic cancer.\n\nA prospective randomized controlled double blinded trial design will be used for the proposed study.",
            "detailedDescription": "The primary objective of this study is to determine the effect of IV lidocaine infusion on various enzymatic activities and associated pathways in isolated CTCs as well as the number of CTCs during the perioperative period in patients undergoing robotic pancreatectomy for pancreatic cancer. It is expected that by downregulating the pathways by lidocaine might affect the enzymatic activity in those CTCs as well as the number of CTCs in the circulation.\n\nA prospective randomized controlled double blinded trial design will be used for the proposed study.\n\nPatients undergoing robotic pancreatectomy for pancreatic cancer will be randomized (ratio 1:1) into two groups: one group will receive a 24-h normal saline infusion and the second group will receive a 24-h lidocaine infusion. Blood samples will be collected in different times perioperatively in order to evaluate the objectives of the study."
        },
        "conditionsModule": {
            "conditions": [
                "Pancreatic Cancer"
            ],
            "keywords": [
                "Pancreas",
                "Pancreatic Cancer",
                "Lidocaine",
                "Enzymatic Activity",
                "Cytokines",
                "Chemokines",
                "Gene Expression"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "EARLY_PHASE1"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "interventionModelDescription": "A prospective randomized placebo-controlled double blinded trial design will be used for the proposed study.",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "DOUBLE",
                    "maskingDescription": "Both patients and the physicians performing the cases will be unaware of who receives lidocaine or placebo.",
                    "whoMasked": [
                        "PARTICIPANT",
                        "CARE_PROVIDER"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 46,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Lidocaine Hydrochloride",
                    "type": "EXPERIMENTAL",
                    "description": "The IV bolus and infusions of lidocaine to those patients assigned to the lidocaine group will be started in the operating room and will continue until 24 h later. The group receiving the lidocaine infusion will first be administered a 1.0 - 1.5 mg/kg loading infusion over 5 minutes followed by a 1.0 - 1.5 mg/kg/h infusion for 24 h",
                    "interventionNames": [
                        "Drug: Lidocaine Hydrochloride"
                    ]
                },
                {
                    "label": "Saline Solution for Injection",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "The group receiving the saline infusion will be administered an equivalent volume of saline infused over 5 min followed by a saline infusion at the same flow rate as that used in the lidocaine group for 24 h (1.0 - 1.5 mg/kg/hr)",
                    "interventionNames": [
                        "Drug: Saline Solution for Injection"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Lidocaine Hydrochloride",
                    "description": "IV Lidocaine a 1.0 - 1.5 mg/kg loading infusion for perioperative pain control",
                    "armGroupLabels": [
                        "Lidocaine Hydrochloride"
                    ],
                    "otherNames": [
                        "Xylocaine"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Saline Solution for Injection",
                    "description": "IV Saline a 1.0 - 1.5 mg/kg loading infusion for perioperative pain control",
                    "armGroupLabels": [
                        "Saline Solution for Injection"
                    ],
                    "otherNames": [
                        "Sodium Chloride"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Specimen outcome measure.",
                    "description": "Src Tyrosine Kinase Enzymatic activity in CTCs. Fluorescence intensity will be used to measure Src phosphorylation in circulating tumor cells.",
                    "timeFrame": "Outcomes will be evaluated perioperatively"
                },
                {
                    "measure": "Specimen outcome measure.",
                    "description": "Cytokine Levels in Serum (pg/ml)",
                    "timeFrame": "Outcomes will be evaluated perioperatively"
                },
                {
                    "measure": "Specimen outcome measure.",
                    "description": "Chemokine levels in serum (pg/ml)",
                    "timeFrame": "Outcomes will be evaluated perioperatively"
                },
                {
                    "measure": "Upregulation or Downregulation of Gene Expression.",
                    "description": "Upregulation or downregulation of gene expression will be measured with the Real Time (RT) square Profiler Polimerase Chain Reaction (PCR )Array Analysis, and Real Time PCR",
                    "timeFrame": "Outcomes will be evaluated perioperatively"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Specimen outcome measure",
                    "description": "CTCs Enumeration",
                    "timeFrame": "Perioperatively"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n1. Has histologically or cytologically confirmed adenocarcinoma of the pancreas that is considered resectable as well as other types of pancreatic cancer (malignant endocrine and exocrine tumors)\n2. Has measurable disease, defined as at least 1 tumor that fulfills the criteria\n3. Patients diagnosed with resectable cancer, but upon initial phase of surgical exploration found to have metastatic disease\n4. Has read, understood and signed the informed consent form (ICF) approved by the Independent Review Board/Independent Ethics Committee (IRB/IEC)\n5. Prior systemic treatments for metastatic disease are permitted, including targeted therapies, biologic response modifiers, chemotherapy, hormonal therapy, or investigational therapy.\n\nExclusion Criteria:\n\n1. Has American Society of Anesthesiologists (ASA) physical status \\> 3\n2. Has hypersensitivity or allergy to amide-linked local anesthetics\n3. Has a second or third degree heart block\n4. Has severe sinoatrial block\n5. Is currently being treated with any of the following class I antiarrhythmic drugs; quinidine, flecainide, disopyramide, or procainamide\n6. Has been treated with amiodarone in the past\n7. Has Adams-Stoke syndrome\n8. Has Wolff-Parkinson-White syndrome\n9. Has a history of blood clots, pulmonary embolism, or deep vein thrombosis unless controlled by anticoagulant treatment\n10. Has a known history of human immunodeficiency virus (HIV) positivity or untreated and uncontrolled hepatitis B or C",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Alexandra Barabanova, MS",
                    "role": "CONTACT",
                    "phone": "(312)996-4020",
                    "email": "barabano@uic.edu"
                },
                {
                    "name": "Gina E. Votta-Velis, MD PhD",
                    "role": "CONTACT",
                    "phone": "(312)996-4020",
                    "email": "barabano@uic.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Gina E. Votta-Velis, MD PhD",
                    "affiliation": "Associate Professor",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "University of Illnois at Chicago",
                    "status": "RECRUITING",
                    "city": "Chicago",
                    "state": "Illinois",
                    "zip": "60612",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Gina E Votta-Velis, MD PhD",
                            "role": "CONTACT",
                            "phone": "312-996-4020",
                            "email": "ginavot@uic.edu"
                        },
                        {
                            "name": "Alexandra Barabanova, MS",
                            "role": "CONTACT",
                            "phone": "(312)355-5733",
                            "email": "barabano@uic.edu"
                        },
                        {
                            "name": "E. Gina Votta-Velis, MD PhD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        },
                        {
                            "name": "Ajay Rana, PhD",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Pier C. Giulianotti, MD",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Alain A. Borgeat, MD",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Sandeep Kumar, PhD",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Antonio Gangemi, MD",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Valentina Valle, MD",
                            "role": "SUB_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.85003,
                        "lon": -87.65005
                    }
                }
            ]
        },
        "referencesModule": {
            "references": [
                {
                    "pmid": "14527919",
                    "type": "BACKGROUND",
                    "citation": "Shakhar G, Ben-Eliyahu S. Potential prophylactic measures against postoperative immunosuppression: could they reduce recurrence rates in oncological patients? Ann Surg Oncol. 2003 Oct;10(8):972-92. doi: 10.1245/aso.2003.02.007."
                },
                {
                    "pmid": "10744945",
                    "type": "BACKGROUND",
                    "citation": "Mokbel K, Choy C, Engledow A. The effect of surgical wounding on tumour development. Eur J Surg Oncol. 2000 Mar;26(2):195. doi: 10.1053/ejso.1999.0771. No abstract available."
                },
                {
                    "pmid": "30640648",
                    "type": "BACKGROUND",
                    "citation": "Missair A, Cata JP, Votta-Velis G, Johnson M, Borgeat A, Tiouririne M, Gottumukkala V, Buggy D, Vallejo R, Marrero EB, Sessler D, Huntoon MA, Andres J, Casasola OL. Impact of perioperative pain management on cancer recurrence: an ASRA/ESRA special article. Reg Anesth Pain Med. 2019 Jan;44(1):13-28. doi: 10.1136/rapm-2018-000001."
                },
                {
                    "pmid": "24218336",
                    "type": "BACKGROUND",
                    "citation": "Han L, Chen W, Zhao Q. Prognostic value of circulating tumor cells in patients with pancreatic cancer: a meta-analysis. Tumour Biol. 2014 Mar;35(3):2473-80. doi: 10.1007/s13277-013-1327-5. Epub 2013 Nov 12."
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000010190",
                    "term": "Pancreatic Neoplasms"
                }
            ],
            "ancestors": [
                {
                    "id": "D000004067",
                    "term": "Digestive System Neoplasms"
                },
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000004701",
                    "term": "Endocrine Gland Neoplasms"
                },
                {
                    "id": "D000004066",
                    "term": "Digestive System Diseases"
                },
                {
                    "id": "D000010182",
                    "term": "Pancreatic Diseases"
                },
                {
                    "id": "D000004700",
                    "term": "Endocrine System Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M13110",
                    "name": "Pancreatic Neoplasms",
                    "asFound": "Pancreatic Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M7256",
                    "name": "Digestive System Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M8886",
                    "name": "Gastrointestinal Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M7863",
                    "name": "Endocrine Gland Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M7255",
                    "name": "Digestive System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8883",
                    "name": "Gastrointestinal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M13102",
                    "name": "Pancreatic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M7862",
                    "name": "Endocrine System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T4387",
                    "name": "Pancreatic Cancer",
                    "asFound": "Pancreatic Cancer",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC06",
                    "name": "Digestive System Diseases"
                },
                {
                    "abbrev": "BC19",
                    "name": "Gland and Hormone Related Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000008012",
                    "term": "Lidocaine"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000779",
                    "term": "Anesthetics, Local"
                },
                {
                    "id": "D000000777",
                    "term": "Anesthetics"
                },
                {
                    "id": "D000002492",
                    "term": "Central Nervous System Depressants"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000018689",
                    "term": "Sensory System Agents"
                },
                {
                    "id": "D000018373",
                    "term": "Peripheral Nervous System Agents"
                },
                {
                    "id": "D000000889",
                    "term": "Anti-Arrhythmia Agents"
                },
                {
                    "id": "D000061567",
                    "term": "Voltage-Gated Sodium Channel Blockers"
                },
                {
                    "id": "D000026941",
                    "term": "Sodium Channel Blockers"
                },
                {
                    "id": "D000049990",
                    "term": "Membrane Transport Modulators"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M11014",
                    "name": "Lidocaine",
                    "asFound": "Pulmonary Hypertension",
                    "relevance": "HIGH"
                },
                {
                    "id": "M21860",
                    "name": "Pharmaceutical Solutions",
                    "relevance": "LOW"
                },
                {
                    "id": "M22554",
                    "name": "Pancrelipase",
                    "relevance": "LOW"
                },
                {
                    "id": "M13114",
                    "name": "Pancreatin",
                    "relevance": "LOW"
                },
                {
                    "id": "M4107",
                    "name": "Anesthetics",
                    "relevance": "LOW"
                },
                {
                    "id": "M4109",
                    "name": "Anesthetics, Local",
                    "relevance": "LOW"
                },
                {
                    "id": "M4213",
                    "name": "Anti-Arrhythmia Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M23177",
                    "name": "Sodium Channel Blockers",
                    "relevance": "LOW"
                },
                {
                    "id": "M30025",
                    "name": "Diuretics, Potassium Sparing",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "AnArAg",
                    "name": "Anti-Arrhythmia Agents"
                },
                {
                    "abbrev": "ChanBlk",
                    "name": "Channel Blockers"
                },
                {
                    "abbrev": "CNSDep",
                    "name": "Central Nervous System Depressants"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "PhSol",
                    "name": "Pharmaceutical Solutions"
                },
                {
                    "abbrev": "Gast",
                    "name": "Gastrointestinal Agents"
                }
            ]
        }
    },
    "hasResults": false
}